Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New developments in nondepolarizing muscle relaxants

¹Department of Anaesthetics, Queen's University of Belfast, Northern Ireland, United Kingdom.

The Yale Journal of Biology and Medicine

|September 1, 1993

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sugammadex and rescue reversal.

Anaesthesia·2011

Same author

Management of neuromuscular block: time for a change?

Anaesthesia·2009

Same author

Sugammadex in clinical practice.

Anaesthesia·2009

Same author

Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.

British journal of anaesthesia·2008

Same author

Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.

Acta anaesthesiologica Scandinavica·2007

Same author

The use of basophil activation to diagnose allergy to Gelofusine.

Anaesthesia·2006

Same journal

Chrysoeriol-Mediated Neuroprotection in Parkinson's Disease in Mice: Targeting Apoptosis, α-Synuclein Accumulation, and Functional Recovery.

The Yale journal of biology and medicine·2026

Same journal

Musicality is Preserved in Neurodegeneration.

The Yale journal of biology and medicine·2026

Same journal

Burden of Neurological Disorders in Resource-Limited Settings: Lessons from Pakistan for Global Neurology.

The Yale journal of biology and medicine·2026

Same journal

Comparative Analysis of Prenatal Stress Models: Placental and Neurodevelopmental Outcomes in Mice.

The Yale journal of biology and medicine·2026

Same journal

Computational Investigation of Flavonoid-Associated Molecular Pathways in Astrogliosis Modulation.

The Yale journal of biology and medicine·2026

Same journal

Regulation and Interaction Among SOCS1 and SOCS3 by MicroRNAs in Multiple Sclerosis: A Review and <i>In Silico</i> Analysis.

The Yale journal of biology and medicine·2026

See all related articles

Anesthesiologists seek ideal muscle relaxants. New nondepolarizing agents like rocuronium offer faster onset and shorter action, addressing unmet clinical needs for improved patient care.

Area of Science:

Anesthesiology
Pharmacology

Background:

The ideal muscle relaxant for anesthesia, particularly a nondepolarizing agent with rapid onset and short duration, remains unavailable.
A need exists for muscle relaxants with varied durations of action and minimal side effects.

Purpose of the Study:

To review the development and characteristics of new muscle relaxant compounds.
To evaluate the potential of recently developed neuromuscular blocking agents in clinical practice.

Main Methods:

Review of pharmacological data and clinical studies on new muscle relaxant compounds.
Comparison of onset, duration, and side effect profiles of doxacurium, pipecuronium, mivacurium, and rocuronium.

Main Results:

Doxacurium and pipecuronium: slow onset, long duration, no cardiovascular side effects.

Related Experiment Videos

Mivacurium: onset similar to atracurium/vecuronium, intermediate duration.

Rocuronium: fast onset (alternative to succinylcholine), vecuronium-like duration.

Conclusions:

New nondepolarizing neuromuscular blocking agents offer diverse profiles to meet clinical demands.
Rocuronium presents a promising alternative to succinylcholine due to its rapid onset and manageable duration.